CNBX Pharmaceuticals Inc (CNBX)
0.0094
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
CNBX Pharmaceuticals Enterprise Value: 1.548M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 1.548M |
| June 13, 2024 | 1.486M |
| June 12, 2024 | 1.501M |
| June 11, 2024 | 1.501M |
| June 10, 2024 | 1.504M |
| June 07, 2024 | 1.504M |
| June 06, 2024 | 1.493M |
| June 05, 2024 | 1.458M |
| June 04, 2024 | 1.458M |
| June 03, 2024 | 1.548M |
| May 31, 2024 | 1.535M |
| May 30, 2024 | 1.532M |
| May 29, 2024 | 1.532M |
| May 28, 2024 | 1.532M |
| May 24, 2024 | 1.560M |
| May 23, 2024 | 1.588M |
| May 22, 2024 | 1.542M |
| May 21, 2024 | 1.542M |
| May 20, 2024 | 1.598M |
| May 17, 2024 | 1.604M |
| May 16, 2024 | 1.629M |
| May 15, 2024 | 1.582M |
| May 14, 2024 | 1.588M |
| May 13, 2024 | 1.552M |
| May 10, 2024 | 1.573M |
| Date | Value |
|---|---|
| May 09, 2024 | 1.567M |
| May 08, 2024 | 1.559M |
| May 07, 2024 | 1.577M |
| May 06, 2024 | 1.573M |
| May 03, 2024 | 1.610M |
| May 02, 2024 | 1.610M |
| May 01, 2024 | 1.598M |
| April 30, 2024 | 1.713M |
| April 29, 2024 | 1.574M |
| April 26, 2024 | 1.591M |
| April 25, 2024 | 1.660M |
| April 24, 2024 | 1.628M |
| April 23, 2024 | 1.640M |
| April 22, 2024 | 1.628M |
| April 19, 2024 | 1.610M |
| April 18, 2024 | 1.579M |
| April 17, 2024 | 1.637M |
| April 16, 2024 | 1.643M |
| April 15, 2024 | 1.619M |
| April 12, 2024 | 1.719M |
| April 11, 2024 | 1.629M |
| April 10, 2024 | 1.676M |
| April 09, 2024 | 1.607M |
| April 08, 2024 | 1.666M |
| April 05, 2024 | 1.598M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.457M
Minimum
Jul 03 2023
73.94M
Maximum
Feb 06 2020
17.30M
Average
14.04M
Median
May 06 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.3255M |
| Revenue (Quarterly) | 0.0406M |
| Total Expenses (Quarterly) | 0.2471M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 84.69% |
| Profit Margin (Quarterly) | -800.9% |
| Earnings Yield | -599.6% |
| Normalized Earnings Yield | -403.05 |